A prospective clinical analysis was carried out to assess the diagnostic and therapeutic impact of fluorodeoxyglucose positron emission tomography (FDG-PET) on planning radiotherapy in patients with advanced head and neck cancer in AJCC Stages III/IV.
Department of Radiation Therapy, University of Regensburg, Franz-Josef-Strauss Allee 11, 93053 Regensburg, Germany. barbara.dietl@klinik.uni-regensburg.de